Quest Diagnostics Launches Gemini-Powered Quest AI Companion To Analyze Up To 5-Years Of Lab Results In MyQuest App

Quest Diagnostics Incorporated +0.17%

Quest Diagnostics Incorporated

DGX

198.02

+0.17%

New feature based on Google's Gemini seamlessly analyzes up to five years of personal lab data to help explain results and uncover potential health risks

SECAUCUS, N.J., March 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on their Quest laboratory test results with their healthcare provider. 

Available now to all adult users of the company's secure, free patient mobile app and portal MyQuest, individuals can engage Quest AI Companion with questions about their test results and immediately receive personalized, easy-to-understand explanations, without leaving the integrated, HIPAA-compliant, MyQuest solution.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.